Cargando…

Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II

Detalles Bibliográficos
Autores principales: Li, Yueyi, Wang, Yusha, Gao, Jinsheng, Tan, Keqin, Frey, Benjamin, Gaipl, Udo S., Shi, Hubing, Ma, Xuelei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352080/
https://www.ncbi.nlm.nih.gov/pubmed/37465680
http://dx.doi.org/10.3389/fimmu.2023.1222675
_version_ 1785074440986427392
author Li, Yueyi
Wang, Yusha
Gao, Jinsheng
Tan, Keqin
Frey, Benjamin
Gaipl, Udo S.
Shi, Hubing
Ma, Xuelei
author_facet Li, Yueyi
Wang, Yusha
Gao, Jinsheng
Tan, Keqin
Frey, Benjamin
Gaipl, Udo S.
Shi, Hubing
Ma, Xuelei
author_sort Li, Yueyi
collection PubMed
description
format Online
Article
Text
id pubmed-10352080
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103520802023-07-18 Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II Li, Yueyi Wang, Yusha Gao, Jinsheng Tan, Keqin Frey, Benjamin Gaipl, Udo S. Shi, Hubing Ma, Xuelei Front Immunol Immunology Frontiers Media S.A. 2023-07-03 /pmc/articles/PMC10352080/ /pubmed/37465680 http://dx.doi.org/10.3389/fimmu.2023.1222675 Text en Copyright © 2023 Li, Wang, Gao, Tan, Frey, Gaipl, Shi and Ma https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Li, Yueyi
Wang, Yusha
Gao, Jinsheng
Tan, Keqin
Frey, Benjamin
Gaipl, Udo S.
Shi, Hubing
Ma, Xuelei
Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II
title Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II
title_full Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II
title_fullStr Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II
title_full_unstemmed Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II
title_short Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II
title_sort editorial: community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume ii
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352080/
https://www.ncbi.nlm.nih.gov/pubmed/37465680
http://dx.doi.org/10.3389/fimmu.2023.1222675
work_keys_str_mv AT liyueyi editorialcommunityseriesinimmunotherapywithcheckpointinhibitorsfornonsmallcelllungcancercoloncancerandesophagealcancervolumeii
AT wangyusha editorialcommunityseriesinimmunotherapywithcheckpointinhibitorsfornonsmallcelllungcancercoloncancerandesophagealcancervolumeii
AT gaojinsheng editorialcommunityseriesinimmunotherapywithcheckpointinhibitorsfornonsmallcelllungcancercoloncancerandesophagealcancervolumeii
AT tankeqin editorialcommunityseriesinimmunotherapywithcheckpointinhibitorsfornonsmallcelllungcancercoloncancerandesophagealcancervolumeii
AT freybenjamin editorialcommunityseriesinimmunotherapywithcheckpointinhibitorsfornonsmallcelllungcancercoloncancerandesophagealcancervolumeii
AT gaipludos editorialcommunityseriesinimmunotherapywithcheckpointinhibitorsfornonsmallcelllungcancercoloncancerandesophagealcancervolumeii
AT shihubing editorialcommunityseriesinimmunotherapywithcheckpointinhibitorsfornonsmallcelllungcancercoloncancerandesophagealcancervolumeii
AT maxuelei editorialcommunityseriesinimmunotherapywithcheckpointinhibitorsfornonsmallcelllungcancercoloncancerandesophagealcancervolumeii